Where have you been, they swept thru the COVID vaccine in no time, if its important enough they will make it happen. Nothing to do with the SEC.
Topline data for AL001 was reported on December 17, 2021 and we are working towards conducting a Phase II multiple-ascending doze study during the second quarter of 2022.
On September 30, 2021, we announced that we received a written response from the FDA to our meeting request relating to our Type B Pre Investigational New Drug (“IND”) application pursuing a combined Phase I/Phase II study as a path for our planned clinical development of AL002. We plan on submitting an IND during the second quarter of 2022.
THey are fast tracking it through. Sophisticated investors are buying the living crap out of this, this will be a 50 dollar stock, probably a lot more as they license the tar out of it, or they just sell the company outright.
Found money and for a great cause
News 
Market Data 
Discover 
AI
